FDA clears Haifa-based Pluristem’s COVID-19 Expanded Access ProgramMore coronavirus patients who do not qualify for the company’s clinical trial will now be able to receive treatmentBiologists work in a laboratory at Pluristem Theraputics in Haifa(photo credit: BAZ RATNER/REUTERS)
